| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.42 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.18 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |